DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

Oncology Homepage

Robotic-assisted transhiatal esophagectomy is safe and effective for certain patients But it's a complex procedure to perform

Margarita Valdez American Society for Radiation oncology hires new assistant director of congressional relations

J. Michael Bruff Varian announces new VP of Investor Relations

Louisiana hospitals deploy Synaptive's BrightMatter technology Builds on earlier investments in neuroscience

Varian to market Bionix brachytherapy applicators in North America Two tools for treating upper GI and anal/rectal cancers

Accuray’s TomoTherapy more effective than Varian’s RapidArc, non-randomized study finds French study examined outcomes for 166 patients

Cancer patient in Italy first to undergo Varian HyperArc radiotherapy Delivers compact radiation doses to tumors with improved targeting

New PET tracer for prostate cancer shows benefits over current standard: study 11C-sarcosine could also be used for other cancers

Praveen Dalmia Karmanos Cancer Institute appoints new corporate director of Oncology Technology & Innovation

Study finds majority of insurance denials overturned in pediatric proton patients Policy language may need revising

Based on one of largest studies
comparing digital and
conventional approaches

Philips IntelliSite Pathology Solution gets FDA clearance for primary diagnostic use

by Lauren Dubinsky , Senior Reporter
Royal Philips announced on Wednesday that the FDA cleared its Philips IntelliSite Pathology Solution (PIPS) for primary diagnostic use. It's the first whole-slide imaging system that can be used to review and interpret digital surgical pathology slide prepared from biopsied tissue.

"[PIPS] allows pathologists to simplify access to histopathology information and work more efficiently," Russ Granzow, general manager of Philips Digital Pathology Solution, told HCB News. "The pathologists will have the agility to view digital images and aim to extend collaboration with peers, with the aim of increasing diagnostic confidence."

Story Continues Below Advertisement

Ventilators Plus -The Easy #1 Choice In Ventilator Sales, Rentals & Support

Our name says it all! Ventilators Plus is a full service depot repair facility offering on-site service as well. We BUY, SELL & RENT all models & also have a FULLY STOCKED parts warehouse available online 24/7. Call 888-889-2992.



As cancer becomes more prevalent, pathologists are under pressure to meet the demand. They have to work as efficiently and effectively as possible to analyze the complex data that's used to design personalized treatments.

PIPS is composed of an ultra-fast pathology slide scanner, an image management system and display monitor. It also comes with advanced software tools to manage the scanning, storage, presentation, reviewing and information sharing processes.

With this solution, pathologists can read tissue slides digitally to make a diagnosis, instead of using a conventional light microscope to look directly at the tissue sample mounted on a glass slide.

"Because the system digitizes slides that would otherwise be stored in physical files, it also provides a streamlined slide storage and retrieval system that may ultimately help make critical health information available to pathologists, other health care professionals and patients faster," Alberto Gutierrez, director of the Office of In Vitro Diagnostics and Radiological Health in the FDA's Center for Devices and Radiological Health, said in a statement.

The agency evaluated data from a clinical study that involved about 2,000 surgical pathology cases. It was one of the largest studies that directly compared the use of digital pathology to conventional optical microscopes.

Sixteen pathologists at Cleveland Clinic, University of Virginia, Miraca Life Sciences and Advanced Pathology Associates performed about 16,000 reads of the cases. The results showed that the diagnoses made using PIPS were comparable to those made using the conventional method.

Previously, PIPS was only approved by the FDA to be used as an aid to the pathologist when detecting HER2 expression in breast cancer. It's now been expanded for primary diagnostic use.

Digital pathology has been a major focus for Philips in recent years. In June 2016, the company acquired PathXL's digital pathology portfolio. More recently in March, they partnered with a developer of artificial intelligence technology for pathology called PathAI.

In the same month, Philips introduced new additions to its pathology solutions portfolio at the 2017 United States and Canadian Academy of Pathology Annual Meeting. That includes research applications called TissueMark and Xplore, and applications for semi-quantification of breast IHC markers.

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED